46 results
Type of content
News Remove News filter
Events Remove Events filter
Documents Remove Documents filter
Categories
Human Remove Human filter
Veterinary Remove Veterinary filter
Corporate Remove Corporate filter
Patient safety
Yes Remove Yes filter
-
List item
Press release: European Medicines Agency recommends restricting Trobalt to last-line therapy in partial epilepsy
CHMP, Last updated: 31/05/2013 -
List item
Press release: European Medicines Agency confirms recommendation to suspend Tredaptive, Pelzont and Trevaclyn
CHMP, Last updated: 18/01/2013 -
List item
Press release: EMA recommends measures to ensure safe use of Keppra oral solution
CHMP, Last updated: 14/10/2016 -
List item
Press release: Omega-3 fatty acid medicines no longer considered effective in preventing heart disease
CHMP, Last updated: 14/12/2018 -
List item
Press release: Disabling and potentially permanent side effects lead to suspension or restrictions of quinolone and fluoroquinolone antibiotics
CHMP, Last updated: 16/11/2018 -
List item
Press release: EMA recommends aligning doses of metamizole medicines and their use during pregnancy and breastfeeding
CHMP, Last updated: 14/12/2018 -
List item
Press release: No new patients should start treatment with Lartruvo after study shows cancer medicine does not prolong life
CHMP, Last updated: 23/01/2019 -
List item
Press release: Sartan medicines: companies to review manufacturing processes to avoid presence of nitrosamine impurities
CHMP, Last updated: 01/02/2019 -
List item
Press release: Increased risk of blood clots in lungs and death with higher dose of Xeljanz (tofacitinib) for rheumatoid arthritis
CHMP, Last updated: 20/03/2019 -
List item
Press release: EMA confirms Xeljanz to be used with caution in patients at high risk of blood clots
CHMP, Last updated: 15/11/2019 -
List item
Press release: New measures to avoid potentially fatal dosing errors with methotrexate for inflammatory diseases
CHMP, Last updated: 23/08/2019 -
List item
Press release: No change is needed in use of direct oral anticoagulants following EMA-funded study
CHMP, Last updated: 27/03/2020 -
List item
Press release: Recommendations to restrict use of fosfomycin antibiotics
CHMP, Last updated: 27/03/2020 -
List item
Press release: Measures to minimise risk of serious side effects of multiple sclerosis medicine Lemtrada
CHMP, Last updated: 15/11/2019 -
List item
Press release: Risks of Picato for actinic keratosis outweigh benefits
CHMP, Last updated: 30/04/2020 -
List item
Press release: Suspension of ranitidine medicines in the EU
CHMP, Last updated: 30/04/2020 -
List item
News: Authorised uses of cancer medicine Yondelis unchanged following review of new data
CHMP, Last updated: 24/07/2020 -
List item
Press release: EMA recommendations on DPD testing prior to treatment with fluorouracil, capecitabine, tegafur and flucytosine
CHMP, Last updated: 30/04/2020 -
List item
News: Ulipristal acetate for uterine fibroids: EMA recommends restricting use
CHMP, Last updated: 13/11/2020 -
List item
News: Nitrosamines: EMA aligns recommendations for sartans with those for other medicines
CHMP, Last updated: 13/11/2020 -
List item
Press release: Benefits of medicines containing combination of methocarbamol and paracetamol continue to outweigh risks
CHMP, Last updated: 27/03/2020